Leelyn Smith LLC Grows Position in The Procter & Gamble Company (NYSE:PG)

Leelyn Smith LLC increased its position in The Procter & Gamble Company (NYSE:PG) by 1.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,770 shares of the company’s stock after purchasing an additional 197 shares during the period. Leelyn Smith LLC’s holdings in Procter & Gamble were worth $3,078,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in PG. Nwam LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth approximately $5,123,000. Meridian Wealth Management LLC bought a new position in shares of Procter & Gamble during the third quarter valued at $10,072,000. Icon Wealth Advisors LLC increased its stake in Procter & Gamble by 4,621.9% during the 3rd quarter. Icon Wealth Advisors LLC now owns 1,285,923 shares of the company’s stock valued at $222,722,000 after purchasing an additional 1,258,690 shares in the last quarter. Studio Investment Management LLC lifted its stake in shares of Procter & Gamble by 0.3% in the third quarter. Studio Investment Management LLC now owns 42,122 shares of the company’s stock worth $7,296,000 after buying an additional 137 shares in the last quarter. Finally, GM Advisory Group LLC grew its holdings in shares of Procter & Gamble by 2.2% during the third quarter. GM Advisory Group LLC now owns 13,959 shares of the company’s stock valued at $2,418,000 after buying an additional 301 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

PG stock opened at $176.26 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The business has a 50-day moving average price of $170.04 and a 200 day moving average price of $168.62. The company has a market capitalization of $415.10 billion, a P/E ratio of 30.39, a PEG ratio of 3.74 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.83 EPS. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.28%. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Insider Buying and Selling

In related news, CEO Jon R. Moeller sold 37,240 shares of the firm’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the transaction, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. This trade represents a 12.38 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 160,693 shares of company stock worth $27,311,345 in the last ninety days. 0.18% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. DA Davidson reaffirmed a “neutral” rating and set a $160.00 price objective on shares of Procter & Gamble in a research report on Wednesday. Royal Bank of Canada reissued a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Finally, Piper Sandler started coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $178.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.